Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 80.00
-0.60 (-0.74%)
Aug 14, 2026, 5:01 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 442.58 million as of August 14, 2026. Its market cap has decreased by -14.41% in one year.
Market Cap
442.58M
Enterprise Value
382.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
80.00
ChartMarket Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 442.58M, an increase of 284.73%. That is a compound annual growth rate of 32.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 442.58M | 15.82% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 580.49M |
| Captor Therapeutics Spolka Akcyjna | 461.89M |
| Ryvu Therapeutics | 404.60M |
| BIOTON | 334.87M |
| Synthaverse | 223.90M |
| Poltreg | 159.15M |
| Molecure | 127.53M |
| Mabion | 122.19M |